Wet AMD

Showing: 1 - 1 of 1 Articles

Outlook Therapeutics® Doses First Subject in NORSE EIGHT

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve FDA approval for the …